These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11472338)

  • 1. Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
    Favier R; Aoki N; de Moerloose P
    Br J Haematol; 2001 Jul; 114(1):4-10. PubMed ID: 11472338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis].
    Leebeek FW; Knot EA; Kluft C
    Ned Tijdschr Geneeskd; 1988 Jan; 132(4):167-70. PubMed ID: 3277073
    [No Abstract]   [Full Text] [Related]  

  • 3. Inherited disorders of the fibrinolytic pathway.
    Jain S; Acharya SS
    Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. May restricted specificity of commercially available plasmin inhibitor activity assays affect correct diagnosis of antiplasmin deficiency?
    Pozzi L; Della Valle P; D'Angelo A
    Blood Coagul Fibrinolysis; 2019 Jan; 30(1):52-53. PubMed ID: 30672814
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis for a patient who had congenital deficiency of alpha 2-plasmin inhibitor.
    Tatematsu M; Higa A; Sunagawa H; Ikehara O; Shiohira Y
    Clin Nephrol; 1998 May; 49(5):335-6. PubMed ID: 9617504
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathologic fibrinolysis as a cause of clinical bleeding.
    Stump DC; Taylor FB; Nesheim ME; Giles AR; Dzik WH; Bovill EG
    Semin Thromb Hemost; 1990 Jul; 16(3):260-73. PubMed ID: 2237447
    [No Abstract]   [Full Text] [Related]  

  • 8. [Contribution of Japanese researchers to progress in the field of hematology in the last 100 years: Congenital deficiency of alpha2-plasmin inhibitor].
    Kamiya T; Aoki N; Saito H; Kohakura S; Koie K
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2062-5. PubMed ID: 12187678
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
    Kluft C; Vellenga E; Brommer EJ; Wijngaards G
    Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
    Colucci G; Alberio L; Jahns M; Keller P; Steiner S; Rüsges-Wolter I; Lämmle B
    Thromb Haemost; 2009 Dec; 102(6):1285-7. PubMed ID: 19967165
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
    Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
    Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel variant causing α2 antiplasmin deficiency: case report and experience in a UK centre.
    Akay M; Zaidi A; Vaidya S; Sivapalaratnam S; Theodoulou A; Platton S; Hart D; Pasi J; Bowles L
    Br J Haematol; 2019 Oct; 187(2):e42-e44. PubMed ID: 31441040
    [No Abstract]   [Full Text] [Related]  

  • 14. Operative treatment of intramedullary hematoma associated with congenital deficiency of alpha 2-plasmin inhibitor, A report of three cases.
    Miyauchi Y; Mii Y; Aoki M; Tamai S; Takahashi Y; Yoshioka A
    J Bone Joint Surg Am; 1996 Sep; 78(9):1409-14. PubMed ID: 8816660
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiological endogenous fibrinolysis: its congenital abnormalities.
    Aoki N
    Nihon Ketsueki Gakkai Zasshi; 1983 Dec; 46(7):1367-73. PubMed ID: 6675397
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blind spots of the diagnostic hemostasis screen].
    Levi M; Peters M; Briët E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive bleeding with fibrinolysis: management with heparin and epsilon aminocaproic acid.
    Bergin JJ; Crosby WH; Jahnke EJ
    Mil Med; 1966 Apr; 131(4):340-4. PubMed ID: 4955920
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency.
    Maino A; Garagiola I; Artoni A; Al-Humood S; Peyvandi F
    Haemophilia; 2008 Jan; 14(1):166. PubMed ID: 17961166
    [No Abstract]   [Full Text] [Related]  

  • 19. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
    Schwartz BS; Williams EC; Conlan MG; Mosher DF
    Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.